Sign in

NCT06754280Active, not recruiting

An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease

An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease: RESET-CKD

Source: ClinicalTrials.gov · Last updated 2 Sept 2026

Brief summary (registry, in English)

RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
23 Dec 2024
Start date
13 Mar 2025
Primary completion date
Dec 2026
Lead sponsor
University of Illinois Chicago
NCT number
NCT06754280

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 13 Mar 2025 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Kidney transplant

Other illness

  • Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension
  • Any other condition that the investigator considers precludes participation in the trial

Other

  • Being unable to walk 1 block
  • Being unable to stand from a seated position without assistance
  • Using a wheelchair, walker, or cane for all of their ambulation
  • Participated in the Patient Advisory Board

Who the study is looking for

  • Self-identifies as Black or African American
  • Age ≥35 to ≤80 years old
  • CKD Stage 1-4
  • Self-reported 6 or more hours/day of sedentary time
  • Ability to speak/read/understand English
  • Has access to a telephone

Age in the registry: 35 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
UI Health/University of Illinois Chicago
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.